Adipotide (FTPP): A Novel Peptide for Targeted Fat Reduction and Metabolic Health
Discover the groundbreaking potential of Adipotide (FTPP) in revolutionizing weight management and metabolic health.
Get a Quote & SampleProduct Core Value
Adipotide FTPP
Adipotide (FTPP) is a pioneering synthetic peptide designed to specifically target the blood vessels that supply white adipose tissue. By disrupting this blood supply, it effectively induces apoptosis (programmed cell death) in fat cells. This targeted approach has demonstrated significant potential in preclinical studies for achieving substantial weight loss and improving insulin resistance, offering a novel avenue for addressing obesity and its associated metabolic complications.
- Mechanism of Action: This peptide's primary mechanism involves binding to prohibitin and Annexin A2 receptors, which are expressed on the endothelial cells of blood vessels supporting white fat tissue. This binding initiates a cascade leading to the selective ablation of these fat cells.
- Weight Loss Efficacy: Preclinical studies in rodents and primates have shown remarkable results, with obese models exhibiting significant reductions in body weight, body mass index, and abdominal circumference following Adipotide treatment.
- Metabolic Improvements: Beyond weight loss, Adipotide has shown promise in improving insulin resistance and glucose tolerance, suggesting a broader impact on metabolic health. This includes potential benefits for individuals managing conditions like type 2 diabetes.
- Targeted Approach: Unlike many traditional weight-loss drugs that focus on appetite suppression or fat absorption, Adipotide acts directly on the adipose tissue vasculature, potentially minimizing off-target effects and offering a safer profile.
Key Advantages
Targeted Fat Ablation
Adipotide's ability to selectively target and eliminate fat cells by disrupting their blood supply is a significant breakthrough, offering a precise method for fat reduction.
Weight-Independent Metabolic Benefits
Research suggests that Adipotide may offer improvements in glucose tolerance independently of overall weight loss, highlighting its potential to directly influence metabolic pathways.
Potential for Obesity Treatment
The promising preclinical results make Adipotide a strong candidate for future development as a therapeutic agent for obesity, a major global health concern.
Key Applications
Obesity Research
Adipotide is a critical tool for researchers investigating novel mechanisms for obesity treatment and understanding fat cell biology.
Metabolic Syndrome Studies
Its impact on insulin resistance and glucose metabolism makes it valuable for studies exploring treatments for metabolic disorders.
Pharmaceutical Intermediate Development
As a high-quality raw material, Adipotide FTPP serves as a crucial intermediate in the development of advanced pharmaceutical products targeting metabolic diseases.
Cancer Research Support
Due to prohibitin's presence in some cancer cells, Adipotide is also being explored for its potential in targeted cancer therapy research.